Perizat Muhamedzhanova

Perizat Muhamedzhanova

Auto-generated profile, based on publicly available information

Perizat Muhamedzhanova

The UMIT Oncological Center of Tomotherapy, Astana, Kazakhstan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Russian Open Medical Journal
Verified
Journal Article
Closed access
AGAnastasia Ganina
Anastasia Ganina
MDMarlen Doskali
Marlen Doskali
LZLina Zaripova
Lina Zaripova
MAManarbek Askarov
Manarbek Askarov
PMPerizat Muhamedzhanova
Perizat Muhamedzhanova
ABAbay Baigenzhin
Abay Baigenzhin
Lung cancer with a five-year survival rate of less than 20% is currently one of the most common malignancies worldwide. Cell-based immunotherapy showed promising results over the past two decades, but some patients still experience disease progression. Numerous studies identified the critical role of the tumor microenvironment in tumor progression, immune evasion, and treatment response. The dynamic interplay between the tumor and its surrounding microenvironment significantly influences both tumor behavior and the immune response. One of the critical components of this interplay is how essential nutrients and structural support are involved in tumor growth per se and cancer pathophysiology in general. A comprehensive understanding of the underlying mechanisms and molecular players critical to the tumor microenvironment is crucial to optimize immunotherapy strategies. This review examines key therapeutic targets in lung cancer, uncovering the complex interactions within the tumor microenvironment to enhance the efficacy of immunotherapy.